Involvement of the Transcription Factor NF-κB in Tubular Morphogenesis of Human Microvascular Endothelial Cells by Oxidative Stress

REFERENCES

• Abe, T., K. Okamura, M. Ono, K. Kohno, T. Mori, S. Hori, and M. Kuwano. 1993. Induction of vascular endothelial tubular morphogenesis by human glioma cells: a model system for tumor angiogenesis. J. Clin. Invest. 92:54–61.
   PubMed Web of Science ®Google Scholar
• Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129–157.
   PubMed Web of Science ®Google Scholar
• Asakuno, K., M. Isono, Y. Wakabayashi, T. Mori, S. Hori, K. Kohno, and M. Kuwano. 1995. The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into the rat brain. Brain Res. 702:23–31.
   PubMedGoogle Scholar
• Baeuerle, P. A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochem. Biophys. Res. Commun. 1072:63–80.
   Google Scholar
• Connolly, D. T., D. M. Heuvelman, R. Nelson, J. V. Olander, B. L. Eppley, and J. J. Delfino. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1470–1478.
   PubMed Web of Science ®Google Scholar
• DeForge, L. E., J. C. Fantone, J. S. Kenney, and D. G. Remick. 1992. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J. Clin. Invest. 90:2123–2129.
   PubMed Web of Science ®Google Scholar
• DeForge, L. E., A. M. Preston, E. Takeuchi, J. Kenney, L. A. Boxer, and D. G. Remick. 1993. Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 268:25568–25576.
   PubMed Web of Science ®Google Scholar
• Fidler, I. J., and L. M. Ellis. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185–188.
   PubMed Web of Science ®Google Scholar
• Finkenzeller, G., D. Marmé, H. A. Weich, and H. Hug. 1992. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res. 52:4821–4823.
   PubMed Web of Science ®Google Scholar
• Finkenzeller, G., A. Technau, and D. Marmé. 1995. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcriptional factor. Biochem. Biophys. Res. Commun. 208:432–439.
   PubMed Web of Science ®Google Scholar
• Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27–31.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D. 1990. NF-κB, KBF1, dorsal, and related matters. Cell 62:841–843.
   PubMed Web of Science ®Google Scholar
• Goldberg, M., and T. J. Schneider. 1994. Similarities between the oxygensensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269:4355–4359.
   PubMed Web of Science ®Google Scholar
• Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1–62.
   PubMed Web of Science ®Google Scholar
• Hamanaka, R., K. Kohno, T. Seguchi, K. Okamura, A. Morimoto, M. Ono, J. Ogata, and M. Kuwano. 1992. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human mi- crovascular endothelial cells. J. Biol. Chem. 267:13160–13165.
   PubMedGoogle Scholar
• Hayashi, T., T. Sekine, and T. Okamoto. 1993. Identification of a new serine kinase that activates NFκB by direct phosphorylation. J. Biol. Chem. 268:26790–26795.
   PubMedGoogle Scholar
• Hayashi, T., Y. Ueno, and T. Okamoto. 1993. Oxidoreductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:11380–11388.
   PubMed Web of Science ®Google Scholar
• Higgins, K., J. R. Perez, T. A. Coleman, K. Dorshkind, W. A. McComas, U. M. Sarmiento, C. A. Rosen, and R. Narayanan. 1993. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90:9901–9905.
   PubMed Web of Science ®Google Scholar
• Hrdličková, R., J. Nehyba, and E. H. Humphries. 1994. In vivo evolution of c-rel oncogenic potential. J. Virol. 68:2371–2382.
   PubMedGoogle Scholar
• Ida, N., S. Sakurai, K. Hosoi, and T. Kunimoto. 1992. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. J. Immunol. Methods 156:27–38.
   PubMedGoogle Scholar
• Izumi, H., M. Ono, S. Ushiro, K. Kohno, H. F. Kung, and M. Kuwano. 1994. Cross talk of tumor necrosis factor-α and epidermal growth factor in human microvascular endothelial cells. Exp. Cell Res. 214:654–662.
   PubMedGoogle Scholar
• Kasahara, T., N. Mukaida, K. Yamashita, H. Yagisawa, T. Akahoshi, and K. Matsushima. 1991. IL-1 and TNF-α induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74:60–67.
   PubMed Web of Science ®Google Scholar
• Kim, K. J., B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (London) 362:841–844.
   PubMed Web of Science ®Google Scholar
• Ko, Y. C., N. Mukaida, A. Panyutich, N. N. Voitenok, K. Matsushima, T. Kawai, and T. Kasahara. 1992. Establishment of sensitive enzyme-linked immunosorbent assay for human IL-8. J. Immunol. Methods 149:227–235.
   PubMed Web of Science ®Google Scholar
• Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage- derived mediator of angiogenesis. Science 258:1798–1801.
   PubMed Web of Science ®Google Scholar
• Kohno, K., R. Hamanaka, T. Abe, Y. Nomura, A. Morimoto, H. Izumi, K. Ito, M. Ono, and M. Kuwano. 1993. Morphological change and destabilization of β-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp. Cell Res. 208:498–503.
   PubMedGoogle Scholar
• Kondo, S., M. Asano, and H. Shimizu. 1993. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem. Biophys. Res. Commun. 194:1234–1241.
   PubMedGoogle Scholar
• Ladoux, A., and C. Frelin. 1993. Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels. Biochem. Biophys. Res. Commun. 194:799–803.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227–229.
   PubMed Web of Science ®Google Scholar
• Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309.
   PubMed Web of Science ®Google Scholar
• Matsukura, M., K. Shinozuka, G. Zon, H. Mitsuya, M. Reitz, J. S. Cohen, and S. Broder. 1987. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84:7706–7710.
   PubMed Web of Science ®Google Scholar
• Matsusaka, T., K. Fujikawa, Y. Nishio, N. Mukaida, K. Matsushima, T. Kishimoto, and S. Akira. 1993. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90:10193–10197.
   PubMed Web of Science ®Google Scholar
• Matsushima, K., K. Morishita, Y. Yoshimura, S. Lavu, Y. Kobayashi, W. Lew, E. Appella, H. F. Kung, E. J. Leonard, and J. J. Oppenheim. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167:1883–1893.
   PubMed Web of Science ®Google Scholar
• Mawatari, M., K. Kohno, H. Mizoguchi, T. Matsuda, K. Asoh, J. Van Damme, H. G. Welgus, and M. Kuwano. 1989. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J. Immunol. 143:1619–1627.
   PubMed Web of Science ®Google Scholar
• Meyer, M., R. Schreck, and P. A. Baeuerle. 1993. H2O2 and antioxidants have opposite effects on activation of NFκB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:2005–2015.
   PubMed Web of Science ®Google Scholar
• Minchenko, A., S. Salceda, T. Bauer, and J. Caro. 1994. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res. 40:35–39.
   PubMedGoogle Scholar
• Montesano, R., J. D. Vassalli, A. Baird, R. Guillemin, and L. Orci. 1986. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83:7297–7301.
   PubMed Web of Science ®Google Scholar
• Morita, M., T. Kasahara, N. Mukaida, T. Nagashima, M. Nishizawa, and M. Yoshida. 1993. Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues. Eur. Cytokine Netw. 4:351–358.
   PubMedGoogle Scholar
• Moscatelli, D. 1987. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 131:123–130.
   PubMed Web of Science ®Google Scholar
• Mukaida, N., M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima. 1994. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kB is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:13289–13295.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, D., L. Tsiokas, X. M. Zhou, D. Foster, J. S. Brugge, and V. P. Sukhatme. 1995. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (London) 375:577–581.
   PubMed Web of Science ®Google Scholar
• Natarajan, V., M. M. Taher, B. Roehm, N. L. Parinandi, H. H. O. Schmid, Z. Kiss, and J. G. M. Garcia. 1993. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J. Biol. Chem. 268:930–937.
   PubMed Web of Science ®Google Scholar
• Nickoloff, B. J., R. S. Mitra, J. Varani, V. M. Dixit, and P. J. Polverini. 1994. Aberrant production of interleukin-8 and thrombospondin-1 psoriatic kera- tinocytes mediates angiogenesis. Am. J. Pathol. 144:820–828.
   PubMed Web of Science ®Google Scholar
• Okamura, K., A. Morimoto, R. Hamanaka, M. Ono, K. Kohno, Y. Uchida, and M. Kuwano. 1992. A model system for tumor angiogenesis: involvement of transforming growth factor-α in tube formation of human microvascular endothelial cells induced by esophageal cancer cells. Biochem. Biophys. Res. Commun. 186:1471–1479.
   PubMed Web of Science ®Google Scholar
• Okamura, K., Y. Sato, T. Matsuda, M. Hamanaka, M. Ono, K. Kohno, and M. Kuwano. 1991. Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. J. Biol. Chem. 266:19162–19165.
   PubMed Web of Science ®Google Scholar
• Oliveira, I. C., N. Mukaida, K. Matsushima, and J. Vilček. 1994. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by NF-κB site. Mol. Cell. Biol. 14:5300–5308.
   PubMedGoogle Scholar
• Ono, M., K. Okamura, Y. Nakayama, M. Tomita, Y. Sato, Y. Komatsu, and M. Kuwano. 1992. Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: involvement of transforming growth factor-α. Biochem. Biophys. Res. Commun. 189:601–609.
   PubMedGoogle Scholar
• Pahl, H. L., and P. A. Baeuerle. 1994. Oxygen and the control of gene expression. Bioessays 16:497–502.
   PubMed Web of Science ®Google Scholar
• Perez, J. R., K. A. Higgins-Sochaski, J.-Y. Maltese, and R. Narayanan. 1994. Regulation of adhesion and growth of fibrosarcoma cells by NF-κB RelA involves transforming growth factor β. Mol. Cell. Biol. 14:5326–5332.
   PubMedGoogle Scholar
• Pierce, E. A., R. L. Avery, E. D. Foley, L. P. Aiello, and L. E. H. Smith. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92:905–909.
   PubMed Web of Science ®Google Scholar
• Rifkin, D. B., and D. Moscatelli. 1989. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1–6.
   PubMed Web of Science ®Google Scholar
• Ryuto, M., and M. Kuwano. Unpublished data.
   Google Scholar
• Samoto, K., K. Ikezaki, M. Ono, T. Shono, K. Kohno, M. Kuwano, and M. Fukui. 1995. The expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 55:1189–1193.
   PubMed Web of Science ®Google Scholar
• Sato, Y., K. Okamura, A. Morimoto, R. Hamanaka, K. Hamaguchi, T. Shimada, M. Ono, K. Kohno, T. Sakata, and M. Kuwano. 1993. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp. Cell Res. 204:223–229.
   PubMed Web of Science ®Google Scholar
• Schenk, H., M. Klein, W. Erdbrugger, and W. Droge. 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NFκB and AP-1. Proc. Natl. Acad. Sci. USA 91:1672–1676.
   PubMed Web of Science ®Google Scholar
• Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2259–2266.
   PubMedGoogle Scholar
• Shatos, M. A., J. M. Doherty, T. Orfeo, J. C. Hoak, D. Collen, and D. C. Stump. 1992. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J. Biol. Chem. 267:567–601.
   Google Scholar
• Shweiki, D., A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359:843–845.
   PubMed Web of Science ®Google Scholar
• Sokoloski, J. A., A. C. Sartorelli, C. A. Rosen, and R. Narayanan. 1993. Antisense oligonucleotides to the p65 subunit of NF-κB block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood 82:625–632.
   PubMedGoogle Scholar
• Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes, and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor. J. Biol. Chem. 266:11947–11954.
   PubMed Web of Science ®Google Scholar
• Van Meir, E., M. Ceska, F. Effenberger, A. Walz, E. Grouzmann, I. Desbaillets, K. Frei, A. Fontana, and N. de Tribolet. 1992. Interleukin-8 is produced in neoplastic and infectious disease of the human central nervous system. Cancer Res. 52:4297–4305.
   PubMed Web of Science ®Google Scholar
• Vercellotti, G. M., S. P. Severson, P. Duane, and C. F. Moldow. 1991. Hydrogen peroxide alters signal transduction in human endothelial cells. J. Lab. Clin. Med. 117:15–24.
   PubMedGoogle Scholar
• Wakabayashi, Y., T. Shono, M. Isono, S. Hori, K. Matsushima, M. Ono, and M. Kuwano. 1995. Dual pathways to tubular morphogenesis of vascular endothelial cells by human glioma cells: VEGF/bFGF and IL-8. Jpn. J. Cancer Res. 86:1798–1801.
   Google Scholar